The inducible caspase-9 suicide gene system as a "safety switch" to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells.
Gargett T, Brown MP. · 2014
Read The inducible caspase-9 suicide gene system as a "safety switch" to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells. by Gargett T, Brown MP. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4211380.txt.
Description
Tessa Gargett and Michael P. Brown reviewed a safety switch for engineered T cells in Frontiers in Pharmacology in 2014. Doctors can fit a patient's T cells with a chimeric antigen receptor that steers them onto cancer cells. The same targeting can strike healthy tissue that shares the marker, a dangerous side effect with no easy brake.
The switch is a gene for inducible caspase-9, an enzyme that triggers cell suicide when a small drug, AP1903, locks two copies together. Cells carrying the switch, above all the most activated ones, die fast after the drug is given. Early trials found the switch reliable. The review covers a third-generation receptor aimed at the GD2 marker on melanoma and related tumours, with the switch built in, then entering phase 1 testing.
Catalog record
| CREATOR | Gargett T, Brown MP. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |